GlycoMimetics Inc (GLYC)
0.3168
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.3133
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Shares Outstanding: 64.48M for Nov. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 13, 2024 | 64.48M |
September 30, 2024 | 64.48M |
August 07, 2024 | 64.48M |
June 30, 2024 | 64.48M |
May 07, 2024 | 64.46M |
March 31, 2024 | 64.45M |
March 25, 2024 | 64.45M |
March 15, 2024 | 64.45M |
December 31, 2023 | 64.39M |
November 01, 2023 | 64.39M |
September 30, 2023 | 64.37M |
July 31, 2023 | 64.32M |
June 30, 2023 | 64.31M |
May 01, 2023 | 64.25M |
March 31, 2023 | 64.25M |
March 27, 2023 | 64.25M |
March 24, 2023 | 64.25M |
December 31, 2022 | 54.38M |
November 07, 2022 | 52.42M |
September 30, 2022 | 52.42M |
August 01, 2022 | 52.42M |
June 30, 2022 | 52.42M |
April 27, 2022 | 52.39M |
April 07, 2022 | 52.39M |
March 31, 2022 | 52.39M |
Date | Value |
---|---|
February 28, 2022 | 52.31M |
December 31, 2021 | 52.31M |
October 29, 2021 | 51.74M |
September 30, 2021 | 51.74M |
August 03, 2021 | 51.54M |
June 30, 2021 | 51.54M |
April 30, 2021 | 51.54M |
March 31, 2021 | 51.54M |
March 24, 2021 | 51.54M |
February 26, 2021 | 51.49M |
December 31, 2020 | 49.02M |
November 04, 2020 | 47.83M |
September 30, 2020 | 47.83M |
July 30, 2020 | 47.72M |
June 30, 2020 | 46.71M |
April 29, 2020 | 43.58M |
April 09, 2020 | 43.58M |
March 31, 2020 | 43.58M |
February 26, 2020 | 43.58M |
December 31, 2019 | 43.47M |
November 04, 2019 | 43.36M |
September 30, 2019 | 43.36M |
July 30, 2019 | 43.19M |
June 30, 2019 | 43.19M |
April 30, 2019 | 43.18M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
43.47M
Minimum
Dec 31 2019
64.48M
Maximum
Jun 30 2024
55.33M
Average
52.39M
Median
Mar 31 2022
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Arbutus Biopharma Corp | 189.49M |
Revance Therapeutics Inc | 104.90M |
FibroGen Inc | 100.77M |
Cidara Therapeutics Inc | 7.047M |